{
  "id": "5c65495be842deac67000021",
  "type": "yesno",
  "question": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
  "ideal_answer": "The FDA approved ivosidenib for patients with IDH1-mutant relapsed/refractory acute myeloid leukemia.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30093505"
  ],
  "snippets": [
    {
      "text": "The FDA approved ivosidenib for patients with IDH1-mutant relapsed/refractory acute myeloid leukemia. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30093505",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}